Crossmark

Wild medicine - exploring medication management challenges in transition and interaction across actors and health sectors related to older adults receiving polypharmacy: a qualitative study

Crossref DOI link: https://doi.org/10.1186/s12877-025-06059-5

Published Online: 2025-07-02

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Wind, Gitte https://orcid.org/0000-0002-4907-4225
Olesen, Karen-Marie https://orcid.org/0009-0007-8715-0747
Andersen, Janne Friis https://orcid.org/0000-0001-8235-1979
Hillersdal, Line https://orcid.org/0000-0002-8137-843X
License Information

Text and Data Mining valid from 2025-07-02

Version of Record valid from 2025-07-02
More Information

Article History

Received: 7 November 2024

Accepted: 19 May 2025

First Online: 2 July 2025

Declarations

:

: Informed consent to participate was obtained from all participants in the study. Participants received verbal and written information about the study that emphasized that they would remain anonymous and could withdraw from the study at any time. The study adhered to the Declaration of Helsinki, was reported to the Danish Data Protection Agency and all data collection and handling was performed in accordance with GDPR rules. According to Danish legislation, health science questionnaire surveys and interview studies that do not involve human biological material require no ethical approval. See paragraph 14 Sect. 2 of the Danish Act on Ethical Treatment of Health Science Research Projects and Health Data Science Research Projects ). Information in English: ()

: All participants gave their written consent for publication.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below